Customized nutritional recipes paired with tailored Baduanjin rehabilitation exercises enhance the comprehensive patient management model, fully improving patients’ quality of life.
XiamenJune 5, 2026 /PRNewswire/ — In a further response to the “Healthy China” initiative, aiming to fill gaps in the comprehensive management of hematologic tumors and promote high-quality development in the diagnosis and treatment of these conditions, the Johnson & Johnson hematologic tumor functional cure themed public welfare project, initiated by Johnson & Johnson and supported by the People’s Good Doctor platform, has undergone a new upgrade.
“A Decade Together, Embracing New Life” 2026 Hematologic Tumor Functional Cure Themed Activity Officially Launched
The upgraded project introduces a comprehensive patient empowerment plan. Building on the existing customized Baduanjin rehabilitation exercises, it launches an exclusive flavor-seeking program for hematologic tumor patients. Collaborating with hematology, nutrition experts, and nursing teams nationwide, and incorporating dietary features from China’s eight major cuisines, it tailors patient-friendly recipes that balance taste experience with daily needs. This establishes a comprehensive management system centered on clinical treatment, integrating physical rehabilitation and daily life support, helping patients better manage their treatment process, improve quality of life, and support their journey toward functional cure.
Currently, the overall burden of hematologic tumors in China ranks among the highest globally. In multiple regions of East Asia, the incidence and mortality rates of multiple myeloma are rapidly rising, posing a new challenge to regional public health[1]. Thanks to the rapid development of hematologic tumor diagnosis and treatment technologies and continuous breakthroughs in various novel therapies, more patients are achieving long-term survival with tumors, pushing previously refractory hematologic tumors like multiple myeloma into an era of chronic disease management.
Professor Lu Jin, Chief Physician of the Hematology Department at Peking University People’s Hospital
Professor Lu Jin, Chief Physician of the Hematology Department at Peking University People’s Hospital, stated that the current treatment goal for multiple myeloma has evolved from “simply prolonging survival” to “achieving sustained deep remission and moving toward functional cure.” The stages of new diagnosis and first relapse are the “golden window” for multiple myeloma treatment. During this phase, through standardized treatment, deeper remission and longer sustained remission lead to longer survival and better quality of life for patients. To successfully achieve “functional cure,” it is also necessary to enhance patients’ adaptability to the treatment process, supporting them in completing long-term standardized treatment.
Demonstration of customized Baduanjin rehabilitation exercises for hematologic tumor patients
This themed activity was held in Xiamen, attracting many hematologic tumor patients and their families to participate. Patients who attended the event expressed that practicing Baduanjin rehabilitation exercises has become a daily habit for them. They are eagerly anticipating the new nutritional recipes and hope that dietary choices more aligned with their tastes and daily routines will bring greater comfort and confidence during treatment.
Addressing the common topic of rehabilitation management among patients at the event, Professor Lu Jin emphasized that for hematologic tumor patients undergoing long-term medication treatment, following medical advice is the primary principle. It is essential to adhere to regular follow-ups and not discontinue medication arbitrarily. Achieving sustained deep remission relies on consensus and cooperation between doctors and patients regarding treatment compliance and comprehensive management. “In clinical practice, we have found that improving patients’ physical fitness, cultivating their scientific disease management abilities, and selecting high-quality treatment drugs are equally important. Whether it’s customized Baduanjin rehabilitation exercises or nutritional recipes tailored to different regional dietary habits, these methods are rooted in patients’ daily lives, easy to implement, and widely accessible. They not only mobilize patients’ initiative but also effectively fill the gaps in out-of-hospital rehabilitation management.”
Exclusive flavor-seeking program for hematologic tumor patients
On the day of the event, the flavor-seeking program for hematologic tumor patients was officially launched. Multiple experts, incorporating regional characteristics, introduced nutritional recipes featuring four major cuisines: Shandong, Zhejiang, Southern Fujian, and Cantonese, balancing taste and dietary health. On-site, doctors and patients practiced the customized Baduanjin rehabilitation exercises together, embodying the rehabilitation concept of combining a balanced diet with moderate exercise. The project will gradually roll out in key cities nationwide this year, continuing to provide disease education, health guidance, and other services, improving the comprehensive management system for hematologic tumors, integrating traditional wellness practices with modern disease management concepts, and accompanying patients on a “flavorful” rehabilitation journey.
Cherry Huang, President of Johnson & Johnson Innovative Medicine China, stated that leveraging its leading hematologic tumor drug pipeline, Johnson & Johnson continues to help patients achieve better treatment outcomes. We understand that medical innovation goes far beyond drug development. The “path to cure” requires not only targeted treatment but also helping patients regain physical strength, rebuild confidence, and embrace a high-quality life. To this end, we collaborate with various parties to continuously advance and upgrade patient empowerment projects, providing them with comprehensive care. This year, we are redefining the dietary experience during treatment—food is not just a necessity for survival but a source of enjoyment, allowing patients to rediscover the pleasure of eating during their recovery process.